Call for Abstracts

Submit your abstract

Topics

Abstracts are welcome across a broad spectrum of subjects in Systemic Autoinflammatory Diseases. When submitting, authors must choose the most appropriate topic category for their abstract on the submission form. The available topic areas are:

• Allied Health Professionals
• Clonal haematopoiesis and auto inflammation
• Autoinflammation in common rheumatologic diseases
• Contribution of algorithms and artificial intelligence in SAIDs
• Innovative therapeutics in Rare Diseases
• Miscellaneous and other
• Designing trials
• VEXAS and hemato-inflammatory disorders
• Monogenic autoinflammatory diseases (clinical)
• Monogenic autoinflammatory diseases (basic science)
• Monogenic autoinflammatory diseases (genetics)
• Non-monogenic SAIDs (clinical)
• Non-monogenic SAIDs (basic science)
• Unusual or unsolved case reports

Presentation types

Abstracts submitted by the deadline of Friday 18 December 2026, 12:00 Noon (CET) will be eligible for consideration for the following presentation types:

• Oral Presentation: selected short talks of 7 minutes + 3 minutes Q&A.
• Presented Poster Walk: 4-minute presentations and 3 minutes of Q&A during allocated time slot time at your poster board in the Poster Walk area in the exhibition hall. Tours are chaired by 1-2 moderators
• Poster Displays: accepted posters will be displayed in the Poster area in the exhibition hall. No dedicated poster presentation timeslots will be allocated to individual presenters. Instead, interactions and scientific exchange will occur during the official breaks.

Rules and guidelines

Please carefully review all instructions and rules regarding abstract submission on this page and within the online submission system before preparing your abstract. Failure to comply may result in disqualification.

General points

• A user account is required to submit an abstract and to register for the Meeting. The account only needs to be created once and may be reused for future submissions and registrations. Authors who submitted for last edition’s Bi-Annual Meeting should use their existing login details.
• If the abstract has been presented at any previous international meeting, please specify the meeting name and date.
• Abstracts may only be submitted through the online submission system; submissions sent by email or post will not be accepted.
• Please ensure your abstract is free of spelling, grammatical, and scientific errors, as it will appear exactly as submitted. Authors are responsible for linguistic accuracy. No proofreading or post-deadline editing will be performed. No changes to the abstract or the version published on the Meeting website will be possible after the submission deadline on 18 December 2026.
• Abstracts will be evaluated based on their relevance to ISSAID, clarity of English, objectivity, methodological rigor, appropriateness of methods, validity of conclusions, ethical standards, scientific impact, clinical relevance, originality, and overall quality.
• Abstracts may be saved in “Draft status” and edited until the submission deadline (Friday 18 December 2026, 12:00 Noon (CET)). Abstracts cannot be edited after the submission deadline.
• Abstracts meeting all requirements may be saved as “Final submission.” Only abstracts marked as “Final submission” will be reviewed for inclusion in the Meeting.
• Submitting authors will be notified by end-January regarding acceptance. Notifications include the date, time and format of presentation, and will be sent to the email address provided during submission.
• To withdraw an abstract, a written request stating the reason must be emailed to the ISSAID Secretariat ([email protected]) no later than Thursday 11 March 2027, 12:00 Noon (CET).

Submission content

• Abstracts must be written in English.
• The same abstract cannot be submitted by more than one author.
• Abstracts must include data and comply with international ethical standards.
• All abbreviations must be defined upon first use.
• Trade names may not appear in the title but may be included in parentheses within the abstract text.
• AI tools may be used only to improve language clarity. AI-generated first drafts are not permitted. Authors bear full responsibility for verifying accuracy after any AI use.
• Abstracts may not exceed 4000 printable characters (including the title, spaces, and line breaks, but excluding author details and conflict-of-interest statements). Please refer to the character count displayed in the submission system, as slight discrepancies may occur between Word documents and other software.
• Abstracts must follow this structure:
  • Introduction
  • Objectives
  • Methods
  • Results
  • Conclusion

One table may be included in the “Results” section with the following criteria: 
- Maximum number of rows: 10
- Maximum number of columns: 10
Image or graph may not be included.

Presentation requirements

• Accepted abstracts will be assigned either as an oral presentation, a poster walk or a poster display.
• Only abstracts submitted by authors who confirm their attendance in Harrogate and complete their registration by Thursday 11 March 2027, 12:00 Noon (CET), will be scheduled and published.
• Presenters will receive a separate email with detailed instructions for confirming their presentation and completing registration. The same user account must be used for both abstract submission and registration; otherwise, the system cannot link the two, and inclusion cannot be guaranteed.
• Each presenting author may present and publish a maximum of 4 abstracts.
• Presenters who do not register and confirm their participation by the deadline may be blacklisted from future ISSAID Meetings.

Publication

Abstracts from presenters who are fully registered will be published exactly as submitted on the Meeting website. Abstracts not presented at the Congress will not be published. The submitting author is responsible for ensuring accuracy of all details, including authorship. No changes will be permitted after the submission deadline.

Submit your abstract